Phase 4 Melioidosis Clinical Trials
4 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–4 of 4 trials
Not Yet Recruiting
Phase 4
A study to determine if a lower dose of the antibiotic trimethoprim/sulfamethoxazole will result in the same clinical cure and fewer side effects as the currently recommended higher dose of trimethoprim/sulfamethoxazole for the treatment of adults with melioidosis.
Melioidosis
Cairns Hospital128 enrolled1 locationACTRN12625001247460
Terminated
Phase 4
A pilot, single-centre, randomised control trial to determine if intensive phase antibiotics alone (intravenous antibiotics for 14 to 42 days) will result in the same clinical outcomes as standard antibiotics (intensive phase antibiotics plus eradication phase antibiotics (90 days of oral antibiotics)) in adults with melioidosis.
Melioidosis
Cairns Hospital60 enrolled1 locationACTRN12622000225718
Completed
Phase 4
A trial of G-CSF in septic shock excluding melioidosis.
Septic shock in adults not caused by melioidosis.
Intensive care unit, Royal Darwin Hospital164 enrolled1 locationACTRN12605000060640
Recruiting
Phase 4
G-CSF for the prevention of mortality from severe melioidosis in Ubon Ratchathani, Thailand
Severe sepsis due to melioidosis
Menzies School of Health Research, Charles Darwin University88 enrolled1 locationACTRN12605000024640